Literature DB >> 20015874

Myelin protein zero is naturally processed in the B cells of monoclonal gammopathy of undetermined significance of immunoglobulin M isotype: aberrant triggering of a patient's T cells.

Eva Hellqvist1, Maria Kvarnström, Anita Söderberg, Magnus Vrethem, Jan Ernerudh, Anders Rosén.   

Abstract

BACKGROUND: Monoclonal gammopathy of undetermined significance of immunoglobulin M isotype is a condition with clonally expanded B cells, recently suggested to have an infectious origin. This monoclonal gammopathy is frequently associated with polyneuropathy and antibodies against myelin protein zero, whereas the role of the T cells remains largely unknown. We analyzed protein zero-specific B cells, as antigen-presenting cells, and their capacity to activate T helper cells. DESIGN AND METHODS: We used a well-characterized monoclonal gammopathy of undetermined significance-derived B-cell line, TJ2, expressing anti-protein zero immunoglobulin M. The ability of TJ2 cells to bind, endocytose, process, and present protein zero was investigated by receptor-clustering and immunofluorescence. The activation of protein zero-specific autologous T cells was studied by measuring interleukin-2 and interferon-gamma with flow cytometry, immunobeads, and enzyme-linked immunospot assays.
RESULTS: Surface-receptor clustering and endocytosis of receptor-ligand (immunoglobulin M/protein zero) complexes were pronounced after exposure to protein zero. Naturally processed or synthetic protein zero peptide (194-208)-pulsed TJ2 cells significantly induced interleukin-2 secretion from autologous T cells compared to control antigen-pulsed cells (P<0.001). The numbers of interferon-gamma-producing T helper cells, including CD4(+)/CD8(+) cells, were also significantly increased (P=0.0152). Affinity-isolated naturally processed myelin peptides were potent interferon-gamma stimulators for autologous peripheral blood mononuclear cells, but not for control peripheral blood mononuclear cells.
CONCLUSIONS: We show for the first time that myelin protein zero is naturally processed in B cells from monoclonal gammopathy of undetermined significance of immunoglobulin M isotype, acting as aberrant antigen-presenting cells in activation of a patient's T helper cells. Our findings cast new light on the important role of autoreactive protein zero-specific B cells in the induction of the pathogenic T-cell responses found in nerve lesions of patients with monoclonal gammopathy of undetermined significance with peripheral neuropathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015874      PMCID: PMC2857193          DOI: 10.3324/haematol.2009.015123

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  61 in total

1.  B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide.

Authors:  J A Lyons; M San; M P Happ; A H Cross
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

2.  A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew F Plevak; L Joseph Melton
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

3.  Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS).

Authors:  M Kvarnstrom; E Sidorova; J Nilsson; C Ekerfelt; M Vrethem; O Soderberg; M Johansson; A Rosen; J Ernerudh
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

4.  Serum IgG antibodies to P0 dimer and 35 kDa P0 related protein in neuropathy associated with monoclonal gammopathy.

Authors:  A Favereaux; A Lagueny; A Vital; J-M Schmitter; S Chaignepain; X Ferrer; I Labatut-Cazabat; C Vital; K G Petry
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

5.  Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events.

Authors:  Surinder S Sahota; Francesco Forconi; Christian H Ottensmeier; Drew Provan; David G Oscier; Terry J Hamblin; Freda K Stevenson
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

6.  Mycobacterium leprae binds to a major human peripheral nerve glycoprotein myelin P zero (P0).

Authors:  Lavanya M Suneetha; Surya S Singh; Meher Vani; Deena Vardhini; David Scollard; Juan J Archelos; M Srinivasulu; Sujai Suneetha
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

7.  Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.

Authors:  John P Bida; Robert A Kyle; Terry M Therneau; L Joseph Melton; Matthew F Plevak; Dirk R Larson; Angela Dispenzieri; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

8.  Comparative proteomics of the Mycobacterium leprae binding protein myelin P0: its implication in leprosy and other neurodegenerative diseases.

Authors:  Deena Vardhini; Sujai Suneetha; Niyaz Ahmed; D S M Joshi; S Karuna; X Magee; D S R Vijayalakshmi; V Sridhar; K V Karunakar; Juan J Archelos; Lavanya M Suneetha
Journal:  Infect Genet Evol       Date:  2004-03       Impact factor: 3.342

9.  Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-beta1a or glatiramer acetate compared with untreated patients.

Authors:  A Jansson; J Ernerudh; M Kvarnström; C Ekerfelt; M Vrethem
Journal:  Mult Scler       Date:  2003-10       Impact factor: 6.312

10.  Prediction of MHC class I binding peptides, using SVMHC.

Authors:  Pierre Dönnes; Arne Elofsson
Journal:  BMC Bioinformatics       Date:  2002-09-11       Impact factor: 3.169

View more
  2 in total

1.  Antibodies to myelin P0 and ceramide perpetuate neuropathy in long standing treated leprosy patients.

Authors:  Renuka Raju; S Karuna Devi; C Mehervani; A Shiva Kumar; A K Meena; P P Reddy; Penaguluru Pranay; Suman Jain; J J Archelos-Gracia; Sujai Suneetha; Lavanya M Suneetha
Journal:  Neurochem Res       Date:  2011-01-14       Impact factor: 3.996

2.  Serological responses to prednisolone treatment in leprosy reactions: study of TNF-α, antibodies to phenolic glycolipid-1, lipoarabinomanan, ceramide and S100-B.

Authors:  Renuka Raju; Sujai Suneetha; Rupendra S Jadhav; MeherVani Chaduvula; Sara Atkinson; Suman Jain; Leo H Visser; Loretta Das; Ravindra Panhalkar; Vidyagouri Shinde; Parphananda P Reddy; Pramila Barkataki; Diana Nj Lockwood; Wim H Van Brakel; Lavanya M Suneetha
Journal:  Lipids Health Dis       Date:  2014-07-28       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.